Opthea Ltd banner

Opthea Ltd
ASX:OPT

Watchlist Manager
Opthea Ltd Logo
Opthea Ltd
ASX:OPT
Watchlist
Price: 0.6 AUD Market Closed
Market Cap: AU$820.8m

Wall Street
Price Targets

OPT Price Targets Summary
Opthea Ltd

There are no price targets for OPT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Opthea Ltd Competitors:
Price Targets
SANA
Sana Biotechnology Inc
175% Upside
STRO
Sutro Biopharma Inc
33% Upside
RCKT
Rocket Pharmaceuticals Inc
68% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
22% Upside

Revenue
Forecast

-14% / Year
Past Growth
157% / Year
Estimated Growth
Estimates Accuracy
41%
Average Beat
-14% / Year
Past Growth
157% / Year
Estimated Growth
Estimates Accuracy
41%
Average Beat

For the last 13 years the compound annual growth rate for Opthea Ltd's revenue is -14%. The projected CAGR for the next 3 years is 157%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPT's stock price target?
Not Available

OPT doesn't have any price targets made by Wall Street professionals.

What is Opthea Ltd's Revenue forecast?
Projected CAGR
157%

For the last 13 years the compound annual growth rate for Opthea Ltd's revenue is -14%. The projected CAGR for the next 3 years is 157%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett